Does AMIVANTAMAB Cause Pneumonitis? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Pneumonitis have been filed in association with AMIVANTAMAB (Rybrevant). This represents 3.2% of all adverse event reports for AMIVANTAMAB.
24
Reports of Pneumonitis with AMIVANTAMAB
3.2%
of all AMIVANTAMAB reports
18
Deaths
18
Hospitalizations
How Dangerous Is Pneumonitis From AMIVANTAMAB?
Of the 24 reports, 18 (75.0%) resulted in death, 18 (75.0%) required hospitalization, and 9 (37.5%) were considered life-threatening.
Is Pneumonitis Listed in the Official Label?
Yes, Pneumonitis is listed as a known adverse reaction in the official FDA drug label for AMIVANTAMAB.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Dyspnoea (23)
Nausea (23)
Neutropenia (23)
What Other Drugs Cause Pneumonitis?
NIVOLUMAB (2,076)
PEMBROLIZUMAB (1,933)
METHOTREXATE (1,188)
PACLITAXEL (1,110)
CARBOPLATIN (975)
EVEROLIMUS (919)
IPILIMUMAB (891)
ATEZOLIZUMAB (842)
DURVALUMAB (827)
RITUXIMAB (747)
Which AMIVANTAMAB Alternatives Have Lower Pneumonitis Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL